Literature DB >> 23732116

Hepatic ERK activity plays a role in energy metabolism.

Ping Jiao1, Bin Feng, Yujie Li, Qin He, Haiyan Xu.   

Abstract

Mitogen activated protein kinases (MAPKs), such as c-Jun N-terminal kinase (JNK) and P38, have been reported to play important roles in energy homeostasis. In this study, we show that the activity of extracellular signal-regulated kinase (ERK) is increased in the livers of diet induced and genetically obese mice. Activation of ERK in the livers of lean mice by over-expressing the constitutively active MAPK kinase 1 (MEK CA) results in decreased energy expenditure, lowered expression of genes involved in fatty acid oxidation, increases fasting hyperglycemia and causes systemic insulin resistance. Interestingly, hepatic glycogen content is markedly increased and expression of G6Pase gene is decreased in mice over-expressing MEK CA compared to control mice expressing green fluorescent protein (GFP), therefore hepatic glucose output is not likely the major contributor of hyperglycemia. One potential mechanism of decreased expression of G6Pase gene by MEK CA is likely due to ERK mediated phosphorylation and cytosolic retention of FOXO1. Adipocytes isolated from MEK CA mice display increased lipolysis. Circulating levels of free fatty acids (FFAs) in these mice are also increased, which possibly contribute to systemic insulin resistance and subsequent hyperglycemia. Consistent with these results, knocking down ERK expression in the liver of diet induced obese (DIO) mice improves systemic insulin and glucose tolerance. These results indicate that increased hepatic ERK activity in DIO mice may contribute to increased liver glycogen content and decreased energy expenditure in obesity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732116      PMCID: PMC3733366          DOI: 10.1016/j.mce.2013.05.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  31 in total

Review 1.  The role of glucose 6-phosphate in the control of glycogen synthase.

Authors:  C Villar-Palasí; J J Guinovart
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

Review 2.  Integration of biochemical and physiologic effects of insulin on glucose metabolism.

Authors:  E A Newsholme; G Dimitriadis
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

3.  Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

4.  Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.

Authors:  H S Camp; S R Tafuri
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

5.  MEK/ERK pathway mediates insulin-promoted degradation of MKP-3 protein in liver cells.

Authors:  Bin Feng; Ping Jiao; Zaiqing Yang; Haiyan Xu
Journal:  Mol Cell Endocrinol       Date:  2012-04-12       Impact factor: 4.102

6.  Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.

Authors:  E Hu; J B Kim; P Sarraf; B M Spiegelman
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

7.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

9.  Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway.

Authors:  R A Gabbay; C Sutherland; L Gnudi; B B Kahn; R M O'Brien; D K Granner; J S Flier
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes.

Authors:  Deepanwita Prusty; Bae-Hang Park; Kathryn E Davis; Stephen R Farmer
Journal:  J Biol Chem       Date:  2002-09-20       Impact factor: 5.157

View more
  37 in total

1.  A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2α phosphorylation in obesity.

Authors:  Takahisa Nakamura; Ryan C Kunz; Cai Zhang; Taishi Kimura; Celvie L Yuan; Brenna Baccaro; Yuka Namiki; Steven P Gygi; Gökhan S Hotamisligil
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

Review 2.  Innate immune regulatory networks in hepatic lipid metabolism.

Authors:  Lan Bai; Hongliang Li
Journal:  J Mol Med (Berl)       Date:  2019-03-19       Impact factor: 4.599

3.  Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.

Authors:  Chune Liu; Zhihong Yang; Jianguo Wu; Li Zhang; Sangmin Lee; Dong-Ju Shin; Melanie Tran; Li Wang
Journal:  Hepatology       Date:  2018-03-25       Impact factor: 17.425

4.  Metarhizium anisopliae s.l. modulation of lipid metabolism during tick infection is independent of AMPK and ERK pathways.

Authors:  Fillipe A Sá; Caio Junior B Coutinho-Rodrigues; Isabele C Angelo; Jéssica P Fiorotti; Georgia C Atella; Vânia Rita E P Bittencourt; Mário Alberto C Silva-Neto
Journal:  Parasitol Res       Date:  2018-01-19       Impact factor: 2.289

5.  Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice.

Authors:  Curtis C Hughey; Freyja D James; Deanna P Bracy; E Patrick Donahue; Jamey D Young; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

6.  Occupational exposures at a polyvinyl chloride production facility are associated with significant changes to the plasma metabolome.

Authors:  John J Guardiola; Juliane I Beier; K Cameron Falkner; Benjamin Wheeler; Craig James McClain; Matt Cave
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-17       Impact factor: 4.219

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.

Authors:  Hung-Tsung Wu; Horng-Yih Ou; Hao-Chang Hung; Yu-Chu Su; Feng-Hwa Lu; Jin-Shang Wu; Yi-Ching Yang; Chao-Liang Wu; Chih-Jen Chang
Journal:  Diabetologia       Date:  2016-05-25       Impact factor: 10.122

9.  Permethrin, a pyrethroid insecticide, regulates ERK1/2 activation through membrane depolarization-mediated pathway in HepG2 hepatocytes.

Authors:  Jason S Yang; Steven Symington; John M Clark; Yeonhwa Park
Journal:  Food Chem Toxicol       Date:  2018-09-08       Impact factor: 6.023

Review 10.  Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.

Authors:  Jesús Burillo; Patricia Marqués; Beatriz Jiménez; Carlos González-Blanco; Manuel Benito; Carlos Guillén
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.